Lyell Immunopharma (LYEL) Operating Margin (QoQ) (2020 - 2026)
Lyell Immunopharma (LYEL) Operating Margin (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Lyell Immunopharma | 298.14 Mn | 298.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.57 Mn |
| Dec 31, 2025 | -187.90 Mn |
| Sep 30, 2025 | 34.09 Mn |
| Jun 30, 2025 | 23.03 Mn |
| Mar 31, 2025 | 100.91 Mn |
| Dec 31, 2024 | -168.01 Mn |
| Sep 30, 2024 | 24.78 Mn |
| Jun 30, 2024 | 145.61 Mn |
| Mar 31, 2024 | -139.47 Mn |
| Dec 31, 2023 | -22.16 Mn |
| Sep 30, 2023 | 793,659.00 |
| Jun 30, 2023 | -14.79 Mn |
| Mar 31, 2023 | -9.62 Mn |
| Dec 31, 2022 | 221.45 Mn |
| Sep 30, 2022 | -221.45 Mn |
| Jun 30, 2022 | 1.23 Mn |
| Mar 31, 2022 | -1.07 Mn |
| Dec 31, 2021 | 9,988.00 |
| Sep 30, 2021 | 60,168.00 |
| Jun 30, 2021 | -12,149.00 |